Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Fitzroy
Clinical trial register · Australia

Clinical Trials in Fitzroy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca15 Janssen Research & Development, LLC14 GlaxoSmithKline12 Hoffmann-La Roche7 AbbVie6
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Fitzroy

173 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Bristol-Myers Squibb
Phase 2
80
Woolloongabba, Fitzroy, Murdoch
2026-11-30
By invitation
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
NCT07197788Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes
Endogenex, Inc.
Not applicable
50
Fitzroy, Melbourne
2026-09
Not yet open
AstraZeneca
Phase 3
750
Brisbane, Camperdown, Darlinghurst, Fitzroy, Melbourne, Nedlands
2026-08-25
Recruiting
AstraZeneca
Phase 3
7,000
Castle Hill, Fitzroy, Gosford, Melbourne, Perth, Southport, St Leonards, Wollongong
2026-08-21
Recruiting
VarmX B.V.
Phase 3
800
Herston, South Brisbane, Southport, Fitzroy, Melbourne, Murdoch
2026-08-18
Recruiting
The Bionics Institute of Australia
Not applicable
5
Fitzroy, Ivanhoe
2026-08-11
Not yet open
VividFlo System Validation Study
NCT07754201Glaucoma
VividWhite Pty Ltd
Not applicable
10
Fitzroy
2026-08-10
Recruiting
VectivBio AG
Phase 3
124
Fitzroy, Heidelberg, Herston, Perth
2026-08
Recruiting
iVEAcare
Not applicable
30
Herston, South Brisbane, Clayton, Fitzroy, Heidelberg, Melbourne, Parkville
2026-07-29
Recruiting
Boehringer Ingelheim
Phase 3
448
Westmead, Adelaide, Fitzroy
2026-07-27
Recruiting
CStone Pharmaceuticals
Phase 1
310
Darlinghurst, North Ryde, Waratah, South Brisbane, Fitzroy, Nedlands
2026-07-16
Recruiting
AstraZeneca
Phase 3
1,200
Botany, East Toowoomba, Fitzroy, Heidelberg Heights, Kingswood, Melbourne, Parkville, Penrith
2026-07-06
Recruiting
AstraZeneca
Phase 3
750
Concord, Darlinghurst, East Melbourne, Fitzroy, Liverpool, Melbourne, Murdoch, Waratah
2026-06-26
Recruiting
Hoffmann-La Roche
Phase 3
380
Fitzroy, Melbourne
2026-06-23
Recruiting
Takeda
Phase 3
300
Coffs Harbour, Sydney, Waratah, Adelaide, Bedford Park, Clayton, Fitzroy, Heidelberg
2026-05-21
Recruiting
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
NCT07486934Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy, Steinert Disease
DrugZeleciment basivarsen
Dyne Therapeutics
Phase 3
150
Fitzroy
2026-05-14
Recruiting
AstraZeneca
Phase 3
420
Adelaide, Fitzroy, Heidelberg, Nedlands, Perth, Rockingham
2026-05-05
Recruiting
Tessera Therapeutics, Inc.
Phase 1/2
72
Fitzroy
2026-04-21
Recruiting
Vergent Bioscience, Inc.
Phase 3
132
Fitzroy
2026-03-31
Recruiting
AstraZeneca
Phase 1
40
Fitzroy, St Albans, Woolloongabba
2026-03-31
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
150
Randwick, Wollongong, Adelaide, Fitzroy, Melbourne
2026-03-26
By invitation
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
NCT07197775Type 2 Diabetes Mellitus (T2DM), Type2Diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes
Endogenex, Inc.
Observational
500
Fitzroy
2026-03-11
Recruiting
AusperBio Therapeutics Inc.
Phase 2
84
Fitzroy
2026-03-06
Recruiting
AstraZeneca
Phase 3
508
Camperdown, Darlinghurst, Fitzroy, Liverpool, Melbourne, Murdoch
2026-02-23
Recruiting
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
NCT07349212Peanut-Induced Anaphylaxis, Peanut Allergy
Ukko Inc
Phase 1/2
40
Camperdown, Bedford Park, Fitzroy, Perth
2026-02-18
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Box Hill, Brisbane, Clayton, Fitzroy, Melbourne, Murdoch, Nedlands, Southport
2026-02-04
Not yet open
St Vincent's Hospital Melbourne
Phase 2
115
Fitzroy, Heidelberg, Melbourne, Parkville
2026-02
Recruiting
AstraZeneca
Phase 1/2
84
Fitzroy, Perth
2026-01-09
Recruiting
AbbVie
Phase 2/3
490
Garran, Kogarah, South Brisbane, Hobart, Fitzroy, St Albans, Nedlands
2025-12-10
Recruiting
Milton S. Hershey Medical Center
Not applicable
324
Fitzroy
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, South Brisbane
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, Parkville, South Brisbane
2025-10-01
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
424
Liverpool, Darlinghurst, Fitzroy, Heidelberg, Nedlands
2025-09-22
Recruiting
BeOne Medicines
Phase 3
500
Concord, Kogarah, Westmead, Benowa, Birtinya, Tugun, Bedford PK, Fitzroy
2025-09-04
Recruiting
Australian Catholic University
Not applicable
20
Fitzroy
2025-09-04
Recruiting
Study of BHV-1300 in Graves' Disease
NCT06980649Graves Disease
DrugBHV-1300
Biohaven Therapeutics Ltd.
Phase 1
15
Fitzroy, Herston, Kotara, Melbourne, Oaklands Park, Parkville, St Leonards, Torquay
2025-08-21
Active, closed
Novo Nordisk A/S
Phase 3
877
Macquarie Park, Wollongong, Townsville, Oaklands Park, Fitzroy, Heidelberg Heights, Parkville
2025-08-11
Recruiting
AbbVie
Phase 1/2
325
Liverpool, Waratah, Fitzroy, Richmond
2025-07-23
By invitation
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
NCT07038447Systemic Lupus Erythematosus, Lupus Nephritis, Systemic Sclerosis, Idiopathic Inflammatory Myopathy
DrugsKITE-363·Fludarabine·Cyclophosphamide
Kite, A Gilead Company
Phase 1
52
Syndey, Fitzroy
2025-07-02
Recruiting
AbbVie
Phase 1/2
602
Coffs Harbour, Port Macquarie, Westmead, South Brisbane, Adelaide, Fitzroy, Melbourne, West Perth
2025-06-30
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bedford Park, Camperdown, Fitzroy, Kogarah, Melbourne, Woolloongabba
2025-06-04
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Kogarah, Brisbane, Clayton, Fitzroy
2025-05-22
Recruiting
Takeda
Phase 3
225
Garran, Sydney, Douglas, Adelaide, Box Hill, Fitzroy, Melbourne, Parkville
2025-05-06
Recruiting
BioNTech SE
Phase 1/2
380
Adelaide, Box Hill, Fitzroy
2025-04-23
Recruiting
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
NCT06714006Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PYC Therapeutics
Phase 1
166
Southport, Concord, Liverpool, Randwick, Wahroonga, Westmead, South Brisbane, Fitzroy
2025-04-07
Recruiting
Gilead Sciences
Phase 3
695
New South Wales, Queensland, Southport, Adelaide, Fitzroy, Nedlands
2025-04-04
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
50
Fitzroy, Maroochydore, Midland
2025-03-31
Recruiting
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
NCT06528301Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL), Lymphoma, Large B-Cell, Diffuse (DLBCL), Chronic Lymphocytic Leukemia (CLL)
DrugsRapamycin·Sirolimus
Umoja Biopharma
Phase 1
106
Saint Leonards, Fitzroy
2025-03-10
Recruiting
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
NCT06824155HER2 Gene Mutation, Advanced Solid Tumors
Radiopharm Theranostics, Ltd
Early Phase 1
30
Kingswood, Macquarie Park, Wollongong, Fitzroy, Murdoch
2025-02-12
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Fitzroy
2025-02-07
Active, closed
Stemline Therapeutics, Inc.
Phase 2
85
Concord, Douglas, Adelaide, Box Hill, Clayton, Fitzroy, Heidelberg, Perth
2025-01-14
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
216
Herston, Adelaide, Clayton, Fitzroy, Melbourne, Parkville, Nedlands
2024-12-30
Recruiting
GlaxoSmithKline
Phase 3
520
Gosford NSW, Box Hill, Melbourne, Fitzroy, Herston, St Leonards
2024-12-16
Recruiting
GlaxoSmithKline
Phase 3
514
Fitzroy
2024-12-12
Recruiting
BMB-101 in Absence Epilepsy and DEE
NCT06401538Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome, Lennox Gastaut Syndrome
DrugBMB-101
Bright Minds Biosciences Pty Ltd
Phase 2
20
Randwick, Herston, Fitzroy, Heidelberg, Melbourne
2024-12-05
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Clayton, Fitzroy, Melbourne, Waratah, Wollongong
2024-12-04
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Fitzroy, Frankston, Sunshine Coast, Campbelltown, Gosford, North Ryde, Concord
2024-11-22
Active, closed
University of Melbourne
Phase 4
352
Fitzroy, Melbourne
2024-11-19
Active, closed
GlaxoSmithKline
Phase 2
283
Westmead, Fitzroy
2024-11-11
Recruiting
Palette Life Sciences, Inc.
Not applicable
84
Fitzroy, Melbourne
2024-10-31
Active, closed
Janssen Research & Development, LLC
Phase 1
19
Concord, Fitzroy, North Ryde
2024-10-22
Active, closed
Uniquity One (UNI)
Phase 2
184
Newcastle, Maroochydore, South Brisbane, Woolloongabba, Box Hill, Fitzroy, Parkville, Murdoch
2024-10-16
Active, closed
Ipsen
Observational
424
Camperdown, Fitzroy
2024-10-14
Recruiting
AstraZeneca
Phase 3
744
Fitzroy, Heidelberg, Kogarah, Liverpool, Nedlands, Port Macquarie, St Leonards, Westmead
2024-10-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Auchenflower, Fitzroy, Hobart
2024-09-03
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Adelaide, Box Hill, Fitzroy, Melbourne, Wollongong
2024-08-28
Active, closed
BioNTech SE
Phase 2
110
Adelaide, Fitzroy, Frankston, St Leonards, Westmead
2024-08-05
Recruiting
AbbVie
Phase 3
170
Waratah, Townsville, Fitzroy, Perth
2024-08-05
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-07-30
Active, closed
Wave Life Sciences USA, Inc.
Phase 1/2
24
Fitzroy
2024-07-19
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Box Hill, Fitzroy, Murdoch
2024-07-16
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Camperdown, Fitzroy, Nedlands, Bedford Park, Woolloongabba
2024-07-09
Active, closed
Sanofi
Phase 2
185
Chermside, South Brisbane, North Adelaide, Box Hill, Fitzroy, Frankston
2024-06-20
Recruiting
Beam Therapeutics Inc.
Phase 1/2
192
Adelaide, Fitzroy
2024-06-19
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Fitzroy, Heidelberg, Melbourne
2024-06-19
Recruiting
Allogene Therapeutics
Phase 2
250
Waratah, Auchenflower, Hobart, Clayton, Fitzroy, Heidelberg, Nedlands
2024-06-18
Recruiting
Mozart Therapeutics Australia Pty Ltd
Phase 1
96
Heidelberg, Melbourne, Fitzroy
2024-06-13
Recruiting
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
NCT06372717Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts, Acute Myeloid Leukemia, in Relapse
Apollo Therapeutics Ltd
Phase 1
100
Clayton, Fitzroy, Melbourne, Nedlands, Perth
2024-06-04
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-05-13
Active, closed
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
NCT06267391Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Diabetes
Endogenex, Inc.
Not applicable
350
Camperdown, Double Bay, Saint Leonards, Box Hill, Fitzroy, Heidelberg, Melbourne
2024-05-01
Active, closed
Gilead Sciences
Phase 2
228
Sydney, South Brisbane, Woolloongabba, Woodville, Clayton, Epping, Fitzroy, Footscray
2024-03-27
Active, closed
AbbVie
Phase 1
152
Camperdown, Ballarat, Fitzroy
2024-03-08
Recruiting
Pfizer
Phase 3
492
Blacktown, Concord, Birtinya, Brisbane, Fitzroy, Geelong, Nedlands
2024-02-08
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Adelaide, Birtinya, Fitzroy, Nedlands, South Brisbane, Waratah
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Adelaide, Box Hill, Darlinghurst, Fitzroy, Southport, West Perth, Wollongong
2024-01-22
Active, closed
VividWhite Pty Ltd
Not applicable
65
Sydney, Bedford Park, Doncaster East, East Melbourne, Fitzroy, Vermont South
2023-12-12
Recruiting
AstraZeneca
Phase 1/2
226
Fitzroy, Melbourne, Nedlands, Wollongong
2023-12-05
Recruiting
Hoffmann-La Roche
Phase 1/2
200
Randwick, Fitzroy
2023-11-14
Active, closed
BeOne Medicines
Phase 3
652
Concord, St Leonards, Benowa, Birtinya, Woolloongabba, Bedford PK, Clayton, Fitzroy
2023-11-11
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Concord, Benowa, Fitzroy, Melbourne, Nedlands
2023-11-01
Active, closed
AstraZeneca
Phase 3
895
Clayton, Fitzroy, Heidelberg, South Brisbane, Sydney
2023-10-24
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Concord, St Leonards, Woolloongabba, Bedford PK, Clayton, Fitzroy, Nedlands, Perth
2023-10-23
Active, closed
AstraZeneca
Phase 3
5,511
Bankstown, Bendigo, Bowral, Brighton, Clayton, Coffs Harbour, Fitzroy, Frankston
2023-10-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Camperdown, St Leonards, Auchenflower, Herston, Adelaide, Hobart, Launceston, Fitzroy
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Concord, Randwick, Douglas, Woolloongabba, Bedford Park, Hobart, Box Hill, Fitzroy
2023-09-18
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Camperdown, Liverpool, Adelaide, Woodville South, Fitzroy
2023-09-13
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
160
Macquarie Park, Wollongong, Ballarat, Bendigo, Fitzroy, Murdoch
2023-08-08
Recruiting
GlaxoSmithKline
Phase 1/2
123
Fitzroy, Nedlands
2023-06-14
Active, closed
Apellis Pharmaceuticals, Inc.
Phase 3
100
Woolloongab, Fitzroy
2023-05-29
Active, closed
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
NCT05650866Erectile Dysfunction Following Radical Prostatectomy
Comphya Australia
Not applicable
20
Fitzroy, Melbourne, North Melbourne, Richmond
2023-05-19
Active, closed
Servier Affaires Médicales
Phase 3
299
Brisbane, Fitzroy, Subiaco, Sydney, Woodville
2023-05-03
Recruiting
The Bionics Institute of Australia
Not applicable
40
East Melbourne, Fitzroy, Geelong, Moonee Ponds, Parkville
2023-05-02
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Randwick, Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
2023-04-25
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Blacktown, Fitzroy, Melbourne, Murdoch, Nedlands
2023-03-29
Recruiting
Takeda
Phase 3
160
Adelaide, Fitzroy
2023-03-06
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Adelaide, Box Hill, Campbelltown, Camperdown, Clayton, Fitzroy, Heidelberg, Herston
2023-02-15
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Southport, Clayton, Fitzroy
2023-01-25
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Concord, Fitzroy, Melbourne, Parkville
2023-01-16
Active, closed
Celcuity Inc
Phase 3
701
Adelaide, Fitzroy, Frankston, Nedlands, South Brisbane, Southport, Wahroonga, Woodville
2022-12-08
Active, closed
Monash University
Phase 3
960
Darlinghurst, Randwick, Westmead, Herston, Woolloongabba, Adelaide, Clayton, Fitzroy
2022-12-01
Recruiting
Pfizer
Phase 3
1,060
Camperdown, Benowa, Fitzroy, Melbourne, Richmond
2022-11-10
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Camperdown, Woolloongabba, Fitzroy
2022-10-24
Active, closed
Hoffmann-La Roche
Phase 1/2
90
Waratah, Fitzroy
2022-10-17
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Adelaide, Fitzroy, Liverpool, Murdoch, Newtown, North Terrace, Parkville, Perth
2022-09-27
Active, closed
Dyne Therapeutics
Phase 1/2
127
Fitzroy
2022-09-05
Active, closed
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
NCT05421663Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse
Janssen Research & Development, LLC
Phase 1/2
166
Fitzroy, Melbourne, Murdoch, Waratah
2022-08-12
Active, closed
THIO Sequenced With Cemiplimab in Advanced NSCLC
NCT05208944Carcinoma, Non-Small-Cell Lung
DrugsThiotepa·Cemiplimab
Maia Biotechnology
Phase 2
227
Buderim, Adelaide, Fitzroy
2022-06-08
Active, closed
AbbVie
Phase 1
34
Liverpool, Fitzroy, Fitzroy Melbourne, Heidelberg, Richmond
2022-05-17
Active, closed
Hoffmann-La Roche
Phase 3
1,300
St Leonards, Fitzroy
2022-05-03
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Garran, Concord, Kogarah, New Lambton Heights, Saint Leonards, Adelaide, Fitzroy, St Albans
2022-04-05
By invitation
UCB Biopharma SRL
Phase 3
300
Fitzroy, Herston, South Brisbane
2022-02-03
Recruiting
Concord Repatriation General Hospital
Not applicable
476
Camperdown, Concord, Gosford, Randwick, Westmead, Brisbane, Fitzroy, Heidelberg
2022-01
Recruiting
Takeda
Phase 2
135
Concord, Tweed Heads, Woodville South, Fitzroy, Melbourne, Wendouree
2021-12-16
Active, closed
Australasian Gastro-Intestinal Trials Group
Not applicable
6
Albury, Bendigo, Box Hill, Epping, Fitzroy, Geelong, Melbourne, Saint Albans
2021-12-14
Active, closed
GlaxoSmithKline
Phase 2
360
Herston, Fitzroy
2021-12-14
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
54
Garran, Albury, Newcastle, Herston, Bedford Park, Fitzroy, Melbourne, Nedlands
2021-12-08
Recruiting
UCB Biopharma SRL
Phase 3
350
Fitzroy, Herston, Melbourne, South Brisbane
2021-12-07
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Adelaide, Camperdown, Randwick, Westmead, Southport, Bedford Park, Clayton, Fitzroy
2021-11-01
Recruiting
Kite, A Gilead Company
Phase 1/2
247
St Leonards, Sydney, Adelaide, Clayton, East Melbourne, Fitzroy
2021-10-27
Recruiting
Pfizer
Phase 3
893
Benowa, Clayfield, Greenslopes, Woolloongabba, East Melbourne, Fitzroy, Geelong, Melbourne
2021-10-04
Active, closed
Janssen Research & Development, LLC
Phase 1
166
Fitzroy, Melbourne, Southport, Wollongong
2021-09-22
Recruiting
BeOne Medicines
Phase 1/2
246
Garran, Kingswood, Clayton, Fitzroy, Melbourne, Perth
2021-09-16
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Concord, Waratah, Woolloongabba, Fitzroy, Heidelberg, Melbourne, Nedlands, West Perth
2021-09-13
Recruiting
St Vincent's Hospital Melbourne
Observational
1,000
Fitzroy
2021-08-26
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Camperdown, Fitzroy, Heidelberg, Herston, Melbourne, Murdoch, Waratah, Westmead
2021-08-19
Active, closed
The Cryopreserved vs. Liquid Platelets Trial
NCT03991481Surgical Blood Loss, Hemorrhage
Australian and New Zealand Intensive Care Research Centre
Phase 3
388
Sydney, Brisbane, Douglas, Southport, Fitzroy, Heidelberg
2021-08-17
Active, closed
GlaxoSmithKline
Phase 1/2
30
Fitzroy
2021-07-29
Recruiting
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
NCT04284839Bleeding Post Cardiac Surgery, Indication for Anticoagulation
DrugsDOAC·Dabigatran·Edoxaban·Warfarin
Population Health Research Institute
Phase 3
3,500
Fitzroy, Parkville
2021-07-18
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Concord, Kogarah, Orange, Southport, Clayton, Fitzroy, Heidelberg, Melbourne
2021-05-24
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Camperdown, Kingswood, Liverpool, Westmead, Southport, Adelaide, Elizabeth Vale, Fitzroy
2021-04-01
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Bendigo, Concord, Fitzroy, Gosford, Kurralta Park, Melbourne, St Albans, Sydney
2021-03-18
Active, closed
Janssen Research & Development, LLC
Phase 1
140
Fitzroy, Melbourne, Waratah
2021-03-12
Active, closed
Hoffmann-La Roche
Phase 3
270
Randwick, Adelaide, Clayton, Fitzroy, Melbourne, Nedlands
2021-02-23
Active, closed
Pfizer
Phase 2
187
Fitzroy, Melbourne, Richmond
2021-02-02
Active, closed
BioNTech SE
Phase 2/3
358
Adelaide, Bedford Park, Fitzroy, Saint Leonards, Tugun, Wollongong
2021-01-07
Active, closed
Janssen Research & Development, LLC
Phase 1/2
228
Fitzroy, Perth
2020-12-15
Active, closed
Amgen
Phase 3
135
Auchenflower, Adelaide, Fitzroy
2020-12-04
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bundaberg, East Melbourne, Fitzroy, Hurstville, North Ryde, Waratah, Wembley
2020-11-12
Active, closed
Study to Evaluate D-1553 in Subjects With Solid Tumors
NCT04585035Solid Tumor, Adult, NSCLC, CRC
DrugD-1553
InventisBio Co., Ltd
Phase 1/2
180
Blacktown, East Albury, Kogarah, Waratah, Woodville South, Fitzroy, Frankston, Malvern
2020-10-02
Active, closed
GlaxoSmithKline
Phase 3
302
Garran, Darlinghurst, Gosford NSW, Port Macquarie, Benowa, South Brisbane, Adelaide, Fitzroy
2020-10-01
Active, closed
Sanofi
Phase 3
337
Liverpool, Waratah, Wollongong, Fitzroy, Heidelberg West, Richmond, Nedlands
2020-06-16
Active, closed
GlaxoSmithKline
Phase 1/2
106
Fitzroy
2020-06-08
Active, closed
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
NCT04416984Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma
DrugsALLO-647·Fludarabine·Cyclophosphamide
Allogene Therapeutics
Phase 1/2
160
Woolloongabba, Clayton, Fitzroy
2020-05-21
Active, closed
GlaxoSmithKline
Phase 3
325
Gosford NSW, Liverpool, St Leonards, Woodville, Hobart, Clayton, Fitzroy, Geelong
2020-04-02
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Macquarie Park, Wollongong, South Brisbane, Woolloongabba, Fitzroy, Frankston
2020-01-29
Active, closed
GlaxoSmithKline
Phase 1
118
Newcastle, Clayton, Fitzroy
2019-12-18
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Adelaide, Box Hill, Clayton, Fitzroy, Melbourne, Richmond
2019-12-16
Active, closed
GlaxoSmithKline
Phase 1/2
25
Fitzroy, Melbourne
2019-11-26
Active, closed
Surveillance AFter Extremity Tumor surgerY
NCT03944798Soft Tissue Sarcoma, Lung Metastases
McMaster University
Not applicable
310
Fitzroy
2019-11-19
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Camperdown, Darlinghurst, Sydney, Chermside, Woolloongabba, Hobart, Fitzroy, Melbourne
2019-09-23
Active, closed
OncoVerity, Inc.
Phase 2
103
Darlinghurst, Fitzroy, Melbourne, Perth, Westmead
2019-07-29
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Gosford, Wollongong, Fitzroy, Warrnambool
2019-03-15
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Albury, Herston, Townsville, Fitzroy, Nedlands
2019-03-11
Recruiting
Imugene Limited
Phase 1
135
Camperdown, Liverpool, Adelaide, Fitzroy, Geelong
2019-03-11
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Clayton, Concord, Fitzroy, Herston, Hobart, Kogarah, Malvern, Nedlands
2018-06-26
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Kogarah, Sydney, Woolloongabba, Bedford Park, Ballarat, Box Hill, Clayton, Fitzroy
2017-05-22
By invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
NCT02796937Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
Grifols Therapeutics LLC
Phase 3
290
Darlinghurst, Adelaide, Chermside, Fitzroy, Nedlands
2016-07
Recruiting
University of Texas Southwestern Medical Center
Phase 3
272
Fitzroy, Geelong
2015-07
Active, closed
AstraZeneca
Phase 3
510
Camperdown, Chermside, Darlinghurst, Fitzroy, Kogarah, Kurralta Park, Malvern, Wendouree
2013-09-25
Recruiting
Monash University
Observational
5,000
Adelaide, Clayton, Fitzroy
2013-09-01
Active, closed
Alliance for Clinical Trials in Oncology
Not applicable
—
Fitzroy
2007-10-12
Rows per page Showing 1–173 of 173
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/fitzroy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 173 of those studies with a site in Fitzroy.

How many clinical trials are recruiting in Fitzroy?

85 of the 173 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 75 are active but closed to new participants, and 9 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Fitzroy), 173 studies
PhaseStudiesRecruitingShare
Phase 3703640.5%
Phase 1/2301917.3%
Phase 224613.9%
Not applicable1789.8%
Phase 117109.8%
Phase 2/3834.6%
Observational422.3%
Phase 4201.2%
Early Phase 1110.6%

Most active sponsors

Lead sponsors with the most studies (Fitzroy)
Lead sponsorStudiesRecruiting
AstraZeneca1510
Janssen Research & Development, LLC145
GlaxoSmithKline124
Hoffmann-La Roche72
AbbVie64
BeOne Medicines64
Pfizer43
Regeneron Pharmaceuticals42
Takeda44
Biohaven Therapeutics Ltd.31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.